Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
    • The aesthetic impact of medication-driven weight loss
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Home
  • Investors

Egypt

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:10
  • Read more about Egypt

See United Arab Emirates

Quality and Pharmacovigilance

El Salvador

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:10
  • Read more about El Salvador

See Mexico

Quality and Pharmacovigilance

Finland

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:09
  • Read more about Finland

See Sweden

Quality and Pharmacovigilance

France

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:07
  • Read more about France

Address:    Galderma International S.A.S.

                    Tour Europlaza – La Défense 4, 20 avenue André Prothin, 

                    92927 PARIS LA DÉFENSE cedex France 

Email:         pharmacovigilance.france@galderma.com

Website:     https://www.galderma.com/france

Quality and Pharmacovigilance

Germany

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:05
  • Read more about Germany

Address:    Galderma Laboratorium GmbH

                   Toulouser Allee 23, 40211 Düsseldorf, Deutschland 

Email:        PV: vigilanz@galderma.com

                   Quality: kundenservice@galderma.com

Website:    https://www.galderma.com/de/qualitaet-und-arzneimittelsicherheit
 

Quality and Pharmacovigilance

Guatemala

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:03
  • Read more about Guatemala

See Mexico

Quality and Pharmacovigilance

Haiti

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:03
  • Read more about Haiti

See United States

Quality and Pharmacovigilance

Honduras

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:02
  • Read more about Honduras

See Mexico

Quality and Pharmacovigilance

Hong Kong/Macau, Greater China

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:00
  • Read more about Hong Kong/Macau, Greater China

Address:    Galderma Hong Kong Limited

                   Suite 3501-02, 35/F, Cambridge House, Taikoo Place,

                   979 King's Road, Island East, Hong Kong 

Email:        pv.hkg@galderma.com

Quality and Pharmacovigilance

Iceland

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 20:00
  • Read more about Iceland

See Sweden

Quality and Pharmacovigilance

Pagination

  • Previous page Previous Page
  • Next page Next Page
Subscribe to Quality and Pharmacovigilance
  1. Home
  2. Quality and Pharmacovigilance

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2025

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back